Nailfold Capillaroscopy in Primary Biliary Cirrhosis: a Useful Tool for the Early Diagnosis of Scleroderma
Author(s) -
Francesco Tovoli,
Alessandro Granito,
Luca Di Giampaolo,
M. Frisoni,
Umberto Volta,
M. Fusconi,
C Masi,
Marco Lenzi
Publication year - 2014
Publication title -
journal of gastrointestinal and liver diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.641
H-Index - 48
eISSN - 1842-1121
pISSN - 1841-8724
DOI - 10.15403/jgld-1277
Subject(s) - medicine , primary biliary cirrhosis , iif , ursodeoxycholic acid , anti nuclear antibody , autoantibody , scleroderma (fungus) , overlap syndrome , gastroenterology , primary sclerosing cholangitis , rheumatology , cirrhosis , antibody , pathology , disease , immunology , inoculation
BACKGROUND & AIMPrimary biliary cirrhosis (PBC) is frequently associated with other autoimmune diseases, including systemic sclerosis (SSc). In the last years many efforts have been dedicated to the research of widely accepted criteria for the early diagnosis of SSc. Since studies on the prevalence of early SSc in PBC patients are lacking, our aim was to investigate its hitherto unknown prevalence in a large cohort of PBC patients.METHODSWe studied 80 PBC patients and 72 patients with other chronic liver diseases. Diagnostic workup included research into signs of connective tissue disease, determination of autoantibody profile, and examination of capillary abnormalities through nailfold videocapillaroscopy.RESULTSTen PBC patients (12.5%) satisfied diagnostic criteria for early SSc and 5 (6.3%) had definite SSc. None of the patients in the control group were diagnosed either with early or definite SSc. No differences were observed in terms of aminotransferases, alkaline phosphatase, and liver function tests between PBC patients with and without associated SSc.CONCLUSIONSEarly SSc is significantly frequent in PBC patients. The detection of early SSc in PBC patients may lead to a prompt treatment of its complications, preventing inabilities and preserving the chance of liver transplantation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom